Fig. 4: The hTNAP18–500-scFv complex. | Nature Communications

Fig. 4: The hTNAP18–500-scFv complex.

From: The structural pathology for hypophosphatasia caused by malfunctional tissue non-specific alkaline phosphatase

Fig. 4

a The cryo-EM map for hTNAP-scFv complex viewed at two angles. The electron density map of TNAP dimer was colored in blue and the electron density map of scFv was colored in green. b The cartoon representation of the TNAP-scFv complex, where the dimeric TNAPs were colored in yellow and blue for protomer A and B, respectively, with two scFv molecules in green. c The epitope mapping on hTNAP18–500. The protomer B was shown as calculated solvent-accessible electrostatic surface-potential maps and the interacting residues from scFv was shown as stick model colored by elements. The critical residues mediating scFv binding were indicated with red frames. d The scFv and scFv-Fc (JTALP001) antibody could increase the alkaline phosphatase activities of hTNAP18–500 protein. optical density (OD). n = 3 biologically independent samples. e The scFv-Fc (JTALP001) antibody showed varing effect of hTNAP18–500 mutants on alkaline phosphatase activities. The mutants of hTNAP18–500 protein were overexpressed in HEK293T and the phosphatase activities in the cell media were measured and calibrated with the expression level as determined by the Western blotting. n = 4 biologically independent samples. All data in this figure are represented as mean ± SD. One-way ANOVA with Tukey’s multiple comparisons test for (e). All experiments were repeated three times independently with similar results. Source data are provided as a Source Data file.

Back to article page